InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,712.69
(
-0.28%
)
US TECH 100
19,431.20
(
-0.34%
)
Dow Jones
41,794.60
(
-0.61%
)
Brent Oil
75.09
(
-0.04%
)
Bitcoin
68,849.56
(
1.52%
)
Post# of 253527
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: biomaven0 post# 84660

Wednesday, 10/07/2009 2:42:01 PM

Wednesday, October 07, 2009 2:42:01 PM

Post# of 253527
Correction:

What I do find weird about her analysis is the way she has linked what happens with M-118 and Copaxone. I grant that if the FDA rejects M-118

That should of course be:

What I do find weird about her analysis is the way she has linked what happens with Lovenox and Copaxone. I grant that if the FDA rejects M-Enoxaparin

Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up